deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT01034670

Advanced Gastrointestinal Endoscopic Imaging

Sponsor: National Cancer Institute (NCI)

Conditions Gastric (Stomach) Cancer Gastrointestinal Diseases Gastrointestinal Stromal Tumor (GIST)
Interventions CellVizio Dual axis endoscopic microscope fluorescein fluorescent Peptide indocyanine green wide field fluorescence system
Updated 13 times since 2017 Last updated: May 31, 2024 Started: Jun 30, 2009 Primary completion: Sep 25, 2017 Completion: Sep 25, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Change in personnel and cessation of funding

Other terminated trials from National Cancer Institute (NCI)

See all terminations from National Cancer Institute (NCI)

This NA trial investigates Gastric (Stomach) Cancer and Gastrointestinal Diseases and is currently terminated or withdrawn. National Cancer Institute (NCI) leads this study, which shows 13 recorded versions since 2009 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~May 2019 · 11 months · monthly snapshot~May 2019 – ~Sep 2020 · 16 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~May 2022 · 12 months · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Jun 2023 · 12 months · monthly snapshot~Jun 2023 – ~Mar 2024 · 9 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

    Status: Recruiting → Terminated

  3. Mar 2024 — Jul 2024 [monthly]

    Recruiting NA

  4. Jun 2023 — Mar 2024 [monthly]

    Recruiting NA

  5. Jun 2022 — Jun 2023 [monthly]

    Recruiting NA

▶ Show 8 earlier versions

  1. May 2022 — Jun 2022 [monthly]

    Recruiting NA

  2. May 2021 — May 2022 [monthly]

    Recruiting NA

  3. Jan 2021 — May 2021 [monthly]

    Recruiting NA

  4. Sep 2020 — Jan 2021 [monthly]

    Recruiting NA

    Status: Suspended → Recruiting

  5. May 2019 — Sep 2020 [monthly]

    Suspended NA

  6. Jun 2018 — May 2019 [monthly]

    Suspended NA

  7. Feb 2017 — Jun 2018 [monthly]

    Suspended NA

  8. Jan 2017 — Feb 2017 [monthly]

    Suspended NA

    First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • National Institutes of Health (NIH)
  • Stanford University
Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations